EverQuote Q3 Earnings & Revenues Top, Automotive Revenues Rise Y/Y
EverQuote's strong Q3 beat on earnings and revenues is powered by double-digit growth in the Automotive and Home insurance segments.
Does EverQuote (EVER) Have the Potential to Rally 48.01% as Wall Street Analysts Expect?
The mean of analysts' price targets for EverQuote (EVER) points to a 48% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
EverQuote: Auto Insurance Demand Is Still Hot
EverQuote remains a "Buy" after a strong post-Q3 earnings rally that demonstrated continued strong demand among auto carriers for new policy switchers. EVER trades at a compelling 6.7x FY26 EV/EBITDA, with accelerating profitability and a large $7 billion TAM in digital insurance advertising. Q3 revenue grew 20% y/y, beating expectations, while adjusted EBITDA rose 33% y/y, highlighting operational leverage and successful cross-selling initiatives.
EverQuote (EVER) Q3 Earnings and Revenues Beat Estimates
EverQuote (EVER) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.31 per share a year ago.
EverQuote, Inc. (EVER) Q3 2025 Earnings Call Transcript
EverQuote, Inc. ( EVER ) Q3 2025 Earnings Call November 3, 2025 4:30 PM EST Company Participants Jayme Mendal - President, CEO & Director Joseph Sanborn - CFO & Treasurer Conference Call Participants Brinlea Johnson - The Blueshirt Group, LLC Maria Ripps - Canaccord Genuity Corp., Research Division Zach Cummins - B. Riley Securities, Inc., Research Division Jason Kreyer - Craig-Hallum Capital Group LLC, Research Division Ralph Schackart - William Blair & Company L.L.C.
EVER Outperforms Industry, Trades at Premium: How to Play the Stock
EverQuote remains poised to gain from its exclusive data asset and technology, intensified focus on core P&C markets and strong financial profile.
EVER Rallies 16.3% YTD, Trades at Premium: Should You Buy the Stock?
EverQuote leans on AI, data and a stronger auto focus to drive growth, but faces rising costs, stiff competition and regulatory risks.
EverQuote Trades Above 200-Day SMA: Time to Buy the Stock?
EVER trades above its 200-day SMA with strong returns and rising quote requests, though challenges remain ahead.
Wall Street Analysts Predict a 36.57% Upside in EverQuote (EVER): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
EverQuote: New Buybacks Signal A Very Healthy Business
I remain bullish on EverQuote, viewing the post-earnings dip as a compelling buy opportunity given strong long-term growth catalysts and a healthy balance sheet. EverQuote targets $1 billion in annual revenue and 20% adjusted EBITDA margins, leveraging AI and product expansion to drive efficiency and profitability. Despite a Q2 revenue miss, auto insurance demand remains robust, and variable marketing margins have stabilized, signaling a profitable steady-state environment.
EverQuote Q2 Earnings & Revenues Beat on Higher Automotive Revenues
EVER's second-quarter results reflect solid performances across both Automotive insurance and Home and Renters insurance verticals, offset by higher expenses.
EverQuote, Inc. (EVER) Q2 2025 Earnings Call Transcript
EverQuote, Inc. (NASDAQ:EVER ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Jayme Mendal - President, CEO & Director Joseph Sanborn - CFO & Treasurer Conference Call Participants Cory Alan Carpenter - JPMorgan Chase & Co, Research Division Jason Michael Kreyer - Craig-Hallum Capital Group LLC, Research Division Jed Kelly - Oppenheimer & Co. Inc., Research Division Maria Ripps - Canaccord Genuity Corp., Research Division Mayank Tandon - Needham & Company, LLC, Research Division Mitchell Rubin - Unidentified Company Ralph Edward Schackart - William Blair & Company L.L.C., Research Division Zachary Cummins - B.
